|
Anne M. VanLent has been a director of the Company since 2004. She has been Executive Vice President and Chief Financial Officer of Barrier Therapeutics Inc. a publicly-traded pharmaceutical company that develops dermatology products since May 2002. Prior to joining Barrier Therapeutics Ms. VanLent served as a principal of the Technology Compass Group LLC a healthcare/technology consulting firm since she founded it in October 2001. From July 1997 to October 2001 she was the Executive Vice President - Portfolio Management for Sarnoff Corporation a multidisciplinary research and development firm. Ms. VanLent also currently serves as a director of Penwest Pharmaceuticals Co. a NASDAQ-listed company. Ms. VanLent received a BA degree in Physics from Mount Holyoke College. | 